Will the Corona problem continue for the coming two years? The researchers say yes, that it might continue for another two years to come.
The COVID-19 pandemic could extend till 2024 as the lower-dose version of its vaccine for 2-4 years olds generated a weaker immune response than expected, Pfizer Inc said.
Pfizer has developed the vaccine with Germany’s BioNTech SE. While a 3-microgram dose of its vaccine was tested on 2-5 year-olds, a 10-microgram dose was used in 5-11 year-olds and 30-microgram doses in everyone over 12.
In children aged 6 to 24 months, the low-dose version of the vaccine generated an immune response consistent with that of older vaccine recipients, Reuters reported.
The company further said that some regions might continue to report COVID cases over the next year or two while others would witness a transition to “endemic” with low and manageable caseloads during the same period, the report added.
With these developments, there is every chance that the work form concept for the employees will be further extended.
